RBC Out Positive On Biogen Hearing Developments, Noting One Of The Judges Is Being Replaced Due To Unavailability; Says Views This As Positive, As This Judge 'eemed most vocal around the potential obviousness of the 480mg dose in BIIB's '514 patent'
Benzinga Newsdesk